Rhenman & Partners Asset Management AB Has $545,000 Stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Rhenman & Partners Asset Management AB decreased its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 87.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 13,750 shares of the company’s stock after selling 92,000 shares during the quarter. Rhenman & Partners Asset Management AB’s holdings in Acadia Healthcare were worth $545,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Landscape Capital Management L.L.C. increased its stake in Acadia Healthcare by 131.7% during the fourth quarter. Landscape Capital Management L.L.C. now owns 37,554 shares of the company’s stock valued at $1,489,000 after acquiring an additional 21,348 shares during the period. Wellington Management Group LLP increased its position in shares of Acadia Healthcare by 0.7% during the fourth quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company’s stock valued at $465,283,000 after purchasing an additional 76,490 shares during the period. Clearbridge Investments LLC raised its stake in shares of Acadia Healthcare by 19.6% in the fourth quarter. Clearbridge Investments LLC now owns 326,886 shares of the company’s stock valued at $12,961,000 after purchasing an additional 53,547 shares in the last quarter. WINTON GROUP Ltd bought a new position in Acadia Healthcare in the fourth quarter worth $436,000. Finally, Zions Bancorporation N.A. boosted its stake in Acadia Healthcare by 14.1% during the fourth quarter. Zions Bancorporation N.A. now owns 14,904 shares of the company’s stock worth $591,000 after buying an additional 1,844 shares in the last quarter.

Acadia Healthcare Stock Down 3.6 %

Shares of ACHC opened at $27.37 on Friday. The business’s 50 day simple moving average is $35.62 and its 200-day simple moving average is $43.59. Acadia Healthcare Company, Inc. has a one year low of $26.72 and a one year high of $82.41. The company has a market capitalization of $2.54 billion, a P/E ratio of 8.97, a PEG ratio of 1.46 and a beta of 1.38. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on ACHC. Mizuho dropped their price objective on shares of Acadia Healthcare from $48.00 to $37.00 and set a “neutral” rating for the company in a research note on Tuesday, March 25th. Bank of America dropped their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research report on Friday, February 28th. Royal Bank of Canada decreased their price objective on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. KeyCorp dropped their target price on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a report on Monday, March 3rd. Finally, StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, Acadia Healthcare has an average rating of “Hold” and a consensus price target of $52.19.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.